Baxter Targets Net Zero By 2050, With Renewable Electricity Goal Due In 2040

The healthcare-products company also set supplier climate goals and a $275 million target for investment in underserved communities.

Share
Baxter Targets Net Zero By 2050, With Renewable Electricity Goal Due In 2040

Baxter International, which makes healthcare products including IV solutions and hospital beds, introduced targets Thursday to reach net-zero operational and purchased-energy emissions by 2050. Its shareholder presentation, supplied through an SEC filing, also sets a 2040 deadline for switching entirely to renewable electricity.

Electricity And Suppliers Have Earlier Deadlines

Baxter's 2050 emissions target covers direct emissions, known as Scope 1, and emissions from purchased energy, known as Scope 2. The company described the goal as aligned with limiting global warming to 1.5 degrees Celsius.

The electricity goal calls for renewable sources to supply 100% of Baxter's electricity by 2040. Its supplier milestone comes earlier: by 2030, it aims for suppliers accounting for 80% of spending in priority categories to have science-based climate targets.

Baxter's environmental program also includes water stewardship and supply-chain management. The company framed the work around reducing environmental impact and making its operations more resilient.

A $275 Million Community Target

Baxter aims to invest $275 million in underserved communities by 2030, measured from a 2021 baseline. It also targets 100,000 employee volunteer hours by 2031, using 2026 as the baseline.

The targets sit within a program spanning sustainable healthcare, climate and resilience, and people and communities. Its healthcare priorities include product quality, patient safety, packaging, sustainable product development, and data security and privacy.

Baxter's business reaches hospitals, nursing homes, rehabilitation centers and patients receiving care at home under physician supervision. Its products range from infusion systems and injectable medicines to patient-monitoring tools and respiratory devices. As of December 31, 2025, it manufactured products in more than 20 countries and sold them in more than 100.

Sustainability Enters Shareholder Discussions

Baxter created its first chief sustainability officer role in 2025 to improve oversight, coordination and accountability.

Sustainability was among the subjects discussed with shareholders that year, alongside strategy, governance, board composition, management succession and executive pay. Baxter contacted investors holding about 68% of its shares and held discussions with investors representing about 61%, based on shares outstanding as of December 31, 2025.

The supplier and community-investment targets fall due in 2030, ahead of the volunteer-hours milestone in 2031 and the longer-term energy and emissions goals.

Sources

More on Baxter International

All Baxter International (BAX) coverage →